Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jun 26, 2026
Jack Allen 's Stock Ratings
Baird Analyst
Jack Allen is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
-17.1%
Smart Score
Overall Average Return Percentile
13th
Number of Ratings
58
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/26/2026 | FTH | Buy Now | Faeth Therapeutics | $26.00 | 119.23% | → $57 | Initiates | → Outperform | Get Alert | |
| 04/27/2026 | NTLA | Buy Now | Intellia Therapeutics | $16.61 | -21.73% | $7 → $13 | Maintains | Neutral | Get Alert | |
| 04/14/2026 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 324.53% | $7 → $9 | Maintains | Outperform | Get Alert | |
| 02/23/2026 | ACLX | Buy Now | Arcellx | — | — | $106 → $115 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/11/2025 | CRSP | Buy Now | CRISPR Therapeutics | $55.00 | -20% | $52 → $44 | Maintains | Neutral | Get Alert | |
| 10/15/2025 | VOR | Buy Now | Vor Biopharma | $16.27 | 293.36% | $20 → $64 | Upgrade | Neutral → Outperform | Get Alert | |
| 10/02/2025 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | 91.08% | $7 → $12 | Maintains | Outperform | Get Alert | |
| 06/27/2025 | VOR | Buy Now | Vor Biopharma | $16.27 | -93.85% | $0.25 → $1 | Maintains | Neutral | Get Alert | |
| 05/14/2025 | FATE | Buy Now | Fate Therapeutics | $2.10 | 90.48% | $5 → $4 | Maintains | Neutral | Get Alert | |
| 05/14/2025 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 324.53% | $12 → $9 | Maintains | Outperform | Get Alert | |
| 12/12/2024 | CARM | Buy Now | CARISMA Therapeutics | $0.01 | 12245.68% | $10 → $1 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/15/2024 | INKT | Buy Now | MiNK Therapeutics | $12.24 | -67.31% | $8 → $4 | Maintains | Outperform | Get Alert | |
| 11/08/2024 | VOR | Buy Now | Vor Biopharma | $16.27 | -13.95% | $22 → $14 | Maintains | Outperform | Get Alert | |
| 11/06/2024 | ACLX | Buy Now | Arcellx | — | — | $77 → $106 | Maintains | Outperform | Get Alert | |
| 10/25/2024 | NTLA | Buy Now | Intellia Therapeutics | $16.61 | 8.37% | $24 → $18 | Maintains | Neutral | Get Alert | |
| 09/16/2024 | TIL | Buy Now | Instil Bio | $7.55 | 2284.11% | $180 → $180 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/13/2024 | TIL | Buy Now | Instil Bio | $7.55 | 2284.11% | $32 → $180 | Maintains | Outperform | Get Alert | |
| 08/15/2024 | BLUE | Buy Now | bluebird bio | — | — | $7 → $6 | Maintains | Outperform | Get Alert | |
| 06/13/2024 | MREO | Buy Now | Mereo BioPharma Group | $0.30 | 2601.79% | → $8 | Initiates | → Outperform | Get Alert | |
| 05/13/2024 | TIL | Buy Now | Instil Bio | $7.55 | 323.84% | $54 → $32 | Maintains | Outperform | Get Alert | |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $55.00 | -5.45% | $46 → $52 | Maintains | Neutral | Get Alert | |
| 02/29/2024 | ACLX | Buy Now | Arcellx | — | — | $63 → $77 | Maintains | Outperform | Get Alert | |
| 01/19/2024 | TIL | Buy Now | Instil Bio | $7.55 | 615.23% | → $54 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/17/2024 | TIL | Buy Now | Instil Bio | $7.55 | 615.23% | $100 → $54 | Maintains | Outperform | Get Alert | |
| 12/12/2023 | BLUE | Buy Now | bluebird bio | — | — | $10 → $7 | Maintains | Outperform | Get Alert | |
| 10/31/2023 | IMCR | Buy Now | Immunocore Hldgs | $30.06 | 179.44% | → $84 | Initiates | → Outperform | Get Alert | |
| 09/26/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | $4 → $0.5 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/15/2023 | ACLX | Buy Now | Arcellx | — | — | $40 → $52 | Maintains | Outperform | Get Alert | |
| 08/15/2023 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | 27.39% | $6 → $8 | Maintains | Outperform | Get Alert | |
| 08/10/2023 | DBTX | Buy Now | Decibel Therapeutics | — | — | $21 → $5.25 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/28/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.01 | 123356.79% | → $10 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/14/2023 | ACLX | Buy Now | Arcellx | — | — | → $39 | Initiates | → Outperform | Get Alert | |
| 04/14/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.01 | 123356.79% | → $10 | Initiates | → Outperform | Get Alert | |
| 04/13/2023 | ACLX | Buy Now | Arcellx | — | — | → $39 | Initiates | → Outperform | Get Alert | |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $16.27 | 35.22% | $38 → $22 | Maintains | Outperform | Get Alert | |
| 03/07/2023 | CRSP | Buy Now | CRISPR Therapeutics | $55.00 | -16.36% | → $46 | Initiates | → Neutral | Get Alert | |
| 03/07/2023 | BLUE | Buy Now | bluebird bio | — | — | → $10 | Initiates | → Outperform | Get Alert | |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $16.61 | 152.86% | $58 → $42 | Maintains | Neutral | Get Alert | |
| 02/14/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | $10 → $4 | Maintains | Outperform | Get Alert | |
| 02/01/2023 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | -4.46% | $10 → $6 | Maintains | Outperform | Get Alert | |
| 01/06/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 466.04% | → $12 | Upgrade | Neutral → Outperform | Get Alert | |
| 11/17/2022 | TIL | Buy Now | Instil Bio | $7.55 | 85.43% | $24 → $14 | Maintains | Outperform | Get Alert | |
| 11/02/2022 | LCTX | Buy Now | Lineage Cell Therapeutics | $1.28 | 290.62% | → $5 | Initiates | → Outperform | Get Alert | |
| 11/02/2022 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $10 | Initiates | → Outperform | Get Alert | |
| 11/01/2022 | TIL | Buy Now | Instil Bio | $7.55 | 217.88% | $31 → $24 | Maintains | Outperform | Get Alert | |
| 10/26/2022 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | 234.39% | $26 → $21 | Maintains | Outperform | Get Alert | |
| 09/13/2022 | RCOR | Buy Now | Renovacor | — | — | → $9 | Initiates | → Outperform | Get Alert | |
| 09/06/2022 | TIL | Buy Now | Instil Bio | $7.55 | 310.6% | $34 → $31 | Maintains | Outperform | Get Alert | |
| 06/03/2022 | FATE | Buy Now | Fate Therapeutics | $2.10 | 1233.33% | → $28 | Initiates | → Neutral | Get Alert | |
| 06/03/2022 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 418.87% | → $11 | Initiates | → Neutral | Get Alert | |
| 05/18/2022 | CLLS | Buy Now | Cellectis | $2.79 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 03/09/2022 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | 314.01% | → $26 | Initiates | → Outperform | Get Alert | |
| 12/03/2021 | VOR | Buy Now | Vor Biopharma | $16.27 | 133.56% | → $38 | Initiates | → Outperform | Get Alert | |
| 11/09/2021 | INKT | Buy Now | MiNK Therapeutics | $12.24 | 112.49% | → $26 | Initiates | → Outperform | Get Alert | |
| 10/22/2021 | DBTX | Buy Now | Decibel Therapeutics | — | — | → $21 | Initiates | → Outperform | Get Alert | |
| 10/08/2021 | CLLS | Buy Now | Cellectis | $2.79 | 258.42% | $39 → $10 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/07/2021 | VYGR | Buy Now | Voyager Therapeutics | $3.59 | 150.7% | $6 → $9 | Upgrade | Neutral → Outperform | Get Alert | |
| 08/13/2021 | TIL | Buy Now | Instil Bio | $7.55 | 350.33% | → $34 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved